Latest Bacillus Calmette-Guérin Stories
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis.
CHADDS FORD, Pa. and BELLEVILLE, Ontario, Feb. 17, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) and Bioniche Life Sciences Inc.
THE HAGUE, The Netherlands, February 15, 2011 /PRNewswire/ -- - The Ministry of Health, Welfare and Sport (Ministerie van Volkgezondheid, Welzijn en Sport) has Announced That it Commences With the Sale of the Production Activities of the 'Nederlands Vaccin Instituut' (NVI). The Sales Process Starts on February 15, 2011. In January 2010 the Minister of Health, Welfare and Sport informed the House of Representatives that the NVI was going to change course.
A team of U.S. and European researchers have found that a new vaccine strategy tested in mice provides stronger, more long-lasting protection from tuberculosis (TB) infection than the vaccine currently used in humans, known as BCG.
A new discovery may explain why a tuberculosis vaccine is not as effective for some people as anticipated, and potentially explains why other vaccines do not work as well for some as they do for others.
SEATTLE, Oct. 16 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute (IDRI) announces it has developed a new tuberculosis (TB) vaccine that protects against TB including drug-resistant strains of the disease in animal studies.
At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis University in St. Louis, Missouri, USA.
Massachusetts General Hospital (MGH) and the Iacocca Foundation announce today the completion of the Phase I BCG clinical trial in type 1 diabetes, as well as the submission of all safety reports to the U.S. Food and Drug Administration (FDA) and the MGH data safety monitoring boards.
VALENCIA, Calif., June 24 /PRNewswire/ -- Today the United States (U.S.) Centers for Disease Control and Prevention (CDC) issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis (TB).
FORT LEE, N.J., Feb. 23 /PRNewswire/ -- A new breath test can detect active pulmonary tuberculosis, according to a report to be published in the journal "Tuberculosis." "The breath test was 85% accurate in detecting patients with active pulmonary tuberculosis," said Dr.
Mycobacterium bovis is a slow-growing, aerobic bacterium and the causative agent of tuberculosis in cattle. Similar to M. tuberculosis, M. bovis can jump the species barrier and cause tuberculosis in humans. It is estimated that M. bovis was responsible for more losses among farm animals than all other diseases combined in the first half of the 20th century. Infection happens after bacterium is ingested. It is generally transmitted to humans via infected milk. Actual human infections are...
- Growing in low tufty patches.